Clinical significance and problems in HCV measurement--comparison of CLEIA method with PCR method

Hirotoshi Ohta, Masao Takemura, Nobuyuki Furuta, Masumi Akiyama, Yasuo Katagiri, Hazuki Ohashi, Kanako Takahashi, Kuniaki Saito, Mitsuru Seishima

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Infection of a hepatitis C virus (HCV) is confirmed by the presence of HCV antibody or HCV-RNA. Recently, a highly sensitive method to examine HCV-core antigen has been developed. In this study, to evaluate the clinical significance of HCV-core antigen determination, we examined serum HCV infection markers, HCV-core antigen, HCV-RNA (AMPLICOR) and HCV-antibody (third generation) concentrations. We determined 225 serum samples, and three patients receiving the treatment with interferon. In 102 HCV-RNA positive samples, significant correlation was observed between HCV-RNA and HCV-core antigen (r=0.734, p<0.0001). However, three out of 102 (2.9%) cases were included within the negative range of HCV-core antigen (20 fmol/l). The HCV-core antigen value in three patients receiving the treatment with interferon paralleled with the amount of HCV-RNA. The determination of HCV-core antigen by CLEIA is a useful and time-saving method, but an attention should be paid to the presence of false-negative cases.

Original languageEnglish
Pages (from-to)813-818
Number of pages6
JournalRinsho byori. The Japanese journal of clinical pathology
Volume52
Issue number10
Publication statusPublished - 01-01-2004
Externally publishedYes

Fingerprint

Hepacivirus
Polymerase Chain Reaction
Antigens
RNA
Hepatitis C Antibodies
Interferons
Virus Diseases
Serum

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Ohta, H., Takemura, M., Furuta, N., Akiyama, M., Katagiri, Y., Ohashi, H., ... Seishima, M. (2004). Clinical significance and problems in HCV measurement--comparison of CLEIA method with PCR method. Rinsho byori. The Japanese journal of clinical pathology, 52(10), 813-818.
Ohta, Hirotoshi ; Takemura, Masao ; Furuta, Nobuyuki ; Akiyama, Masumi ; Katagiri, Yasuo ; Ohashi, Hazuki ; Takahashi, Kanako ; Saito, Kuniaki ; Seishima, Mitsuru. / Clinical significance and problems in HCV measurement--comparison of CLEIA method with PCR method. In: Rinsho byori. The Japanese journal of clinical pathology. 2004 ; Vol. 52, No. 10. pp. 813-818.
@article{24d7e0c75c1e4300b9bca0abc869d4d9,
title = "Clinical significance and problems in HCV measurement--comparison of CLEIA method with PCR method",
abstract = "Infection of a hepatitis C virus (HCV) is confirmed by the presence of HCV antibody or HCV-RNA. Recently, a highly sensitive method to examine HCV-core antigen has been developed. In this study, to evaluate the clinical significance of HCV-core antigen determination, we examined serum HCV infection markers, HCV-core antigen, HCV-RNA (AMPLICOR) and HCV-antibody (third generation) concentrations. We determined 225 serum samples, and three patients receiving the treatment with interferon. In 102 HCV-RNA positive samples, significant correlation was observed between HCV-RNA and HCV-core antigen (r=0.734, p<0.0001). However, three out of 102 (2.9{\%}) cases were included within the negative range of HCV-core antigen (20 fmol/l). The HCV-core antigen value in three patients receiving the treatment with interferon paralleled with the amount of HCV-RNA. The determination of HCV-core antigen by CLEIA is a useful and time-saving method, but an attention should be paid to the presence of false-negative cases.",
author = "Hirotoshi Ohta and Masao Takemura and Nobuyuki Furuta and Masumi Akiyama and Yasuo Katagiri and Hazuki Ohashi and Kanako Takahashi and Kuniaki Saito and Mitsuru Seishima",
year = "2004",
month = "1",
day = "1",
language = "English",
volume = "52",
pages = "813--818",
journal = "Rinsho byori. The Japanese journal of clinical pathology",
issn = "0047-1860",
publisher = "Nihon Rinsho Byori Gakkai",
number = "10",

}

Ohta, H, Takemura, M, Furuta, N, Akiyama, M, Katagiri, Y, Ohashi, H, Takahashi, K, Saito, K & Seishima, M 2004, 'Clinical significance and problems in HCV measurement--comparison of CLEIA method with PCR method', Rinsho byori. The Japanese journal of clinical pathology, vol. 52, no. 10, pp. 813-818.

Clinical significance and problems in HCV measurement--comparison of CLEIA method with PCR method. / Ohta, Hirotoshi; Takemura, Masao; Furuta, Nobuyuki; Akiyama, Masumi; Katagiri, Yasuo; Ohashi, Hazuki; Takahashi, Kanako; Saito, Kuniaki; Seishima, Mitsuru.

In: Rinsho byori. The Japanese journal of clinical pathology, Vol. 52, No. 10, 01.01.2004, p. 813-818.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical significance and problems in HCV measurement--comparison of CLEIA method with PCR method

AU - Ohta, Hirotoshi

AU - Takemura, Masao

AU - Furuta, Nobuyuki

AU - Akiyama, Masumi

AU - Katagiri, Yasuo

AU - Ohashi, Hazuki

AU - Takahashi, Kanako

AU - Saito, Kuniaki

AU - Seishima, Mitsuru

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Infection of a hepatitis C virus (HCV) is confirmed by the presence of HCV antibody or HCV-RNA. Recently, a highly sensitive method to examine HCV-core antigen has been developed. In this study, to evaluate the clinical significance of HCV-core antigen determination, we examined serum HCV infection markers, HCV-core antigen, HCV-RNA (AMPLICOR) and HCV-antibody (third generation) concentrations. We determined 225 serum samples, and three patients receiving the treatment with interferon. In 102 HCV-RNA positive samples, significant correlation was observed between HCV-RNA and HCV-core antigen (r=0.734, p<0.0001). However, three out of 102 (2.9%) cases were included within the negative range of HCV-core antigen (20 fmol/l). The HCV-core antigen value in three patients receiving the treatment with interferon paralleled with the amount of HCV-RNA. The determination of HCV-core antigen by CLEIA is a useful and time-saving method, but an attention should be paid to the presence of false-negative cases.

AB - Infection of a hepatitis C virus (HCV) is confirmed by the presence of HCV antibody or HCV-RNA. Recently, a highly sensitive method to examine HCV-core antigen has been developed. In this study, to evaluate the clinical significance of HCV-core antigen determination, we examined serum HCV infection markers, HCV-core antigen, HCV-RNA (AMPLICOR) and HCV-antibody (third generation) concentrations. We determined 225 serum samples, and three patients receiving the treatment with interferon. In 102 HCV-RNA positive samples, significant correlation was observed between HCV-RNA and HCV-core antigen (r=0.734, p<0.0001). However, three out of 102 (2.9%) cases were included within the negative range of HCV-core antigen (20 fmol/l). The HCV-core antigen value in three patients receiving the treatment with interferon paralleled with the amount of HCV-RNA. The determination of HCV-core antigen by CLEIA is a useful and time-saving method, but an attention should be paid to the presence of false-negative cases.

UR - http://www.scopus.com/inward/record.url?scp=16644399907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16644399907&partnerID=8YFLogxK

M3 - Article

C2 - 15624496

AN - SCOPUS:16644399907

VL - 52

SP - 813

EP - 818

JO - Rinsho byori. The Japanese journal of clinical pathology

JF - Rinsho byori. The Japanese journal of clinical pathology

SN - 0047-1860

IS - 10

ER -